Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Adam

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|September 25, 2020
Adipose Tissue Properties in Tumor-Bearing BreastsIsabelle Miran, Dominique Scherer, Pauline Ostyn, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Oncoimmunology|November 18, 2016
The ratio of CD8<sup>+</sup>/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma <i>in situ</i>Michaela Semeraro, Julien Adam, Gautier Stoll, et al.
Journal of Surgical Oncology|June 13, 2021
Surgical management of soft tissue tumors of the abdominal wall: A retrospective study in a high-volume sarcoma centerMaud Neuberg, Olivier Mir, Antonin Levy, et al.
Molecular Cancer Therapeutics|April 3, 2015
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck CancerMichele Mondini, Mevyn Nizard, Thi Tran, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patientsLaura Mezquita, Melinda Charrier, Laura Faivre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
Cancer Research|January 31, 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF HeterodimerizationLise Boussemart, Isabelle Girault, Hélène Malka-Mahieu, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|September 25, 2020
Adipose Tissue Properties in Tumor-Bearing BreastsIsabelle Miran, Dominique Scherer, Pauline Ostyn, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Oncoimmunology|November 18, 2016
The ratio of CD8<sup>+</sup>/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma <i>in situ</i>Michaela Semeraro, Julien Adam, Gautier Stoll, et al.
Journal of Surgical Oncology|June 13, 2021
Surgical management of soft tissue tumors of the abdominal wall: A retrospective study in a high-volume sarcoma centerMaud Neuberg, Olivier Mir, Antonin Levy, et al.
Molecular Cancer Therapeutics|April 3, 2015
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck CancerMichele Mondini, Mevyn Nizard, Thi Tran, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patientsLaura Mezquita, Melinda Charrier, Laura Faivre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
Cancer Research|January 31, 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF HeterodimerizationLise Boussemart, Isabelle Girault, Hélène Malka-Mahieu, et al.
Pageof 16